Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73M Sell
285,186
-51,194
-15% -$339K ﹤0.01% 2116
2026
Q1
$1.74M Buy
336,380
+19,460
+6% +$122K ﹤0.01% 2104
2025
Q4
$2.32M Buy
316,920
+9,426
+3% +$91.3K ﹤0.01% 1829
2025
Q3
$3.07M Sell
307,494
-347,675
-53% -$3.85M ﹤0.01% 1583
2025
Q2
$5.93M Buy
655,169
+246,000
+60% +$1.6M ﹤0.01% 1632
2025
Q1
$2.63M Buy
409,169
+63,630
+18% +$566K ﹤0.01% 1865
2024
Q4
$3.29M Buy
345,539
+65,126
+23% +$572K ﹤0.01% 1810
2024
Q3
$2.29M Sell
280,413
-19,283
-6% -$200K ﹤0.01% 1971
2024
Q2
$4.05M Buy
299,696
+74,166
+33% +$620K ﹤0.01% 1602
2024
Q1
$1.58M Buy
225,530
+13,922
+7% +$121K ﹤0.01% 1792
2023
Q4
$2.32M Buy
211,608
+43,427
+26% +$426K ﹤0.01% 1620
2023
Q3
$1.85M Buy
168,181
+73,611
+78% +$1.05M ﹤0.01% 1666
2023
Q2
$1.23M Hold
94,570
﹤0.01% 1906
2023
Q1
$1.23M Buy
94,570
+15,832
+20% +$130K ﹤0.01% 1906
2022
Q4
$857K Sell
78,738
-137
-0.2% -$1.69K ﹤0.01% 1920
2022
Q3
$1.27M Buy
78,875
+4,838
+7% +$71.4K ﹤0.01% 1833
2022
Q2
$577K Buy
74,037
+17,484
+31% +$164K ﹤0.01% 2251
2022
Q1
$706K Buy
56,553
+28,102
+99% +$394K ﹤0.01% 2312
2021
Q4
$679K Buy
+28,451
New +$689K ﹤0.01% 2414

Other funds holding ENVX

UBS AM's ENVX Position: Q2 2026 in Review

UBS AM reduced its Enovix (ENVX) stake by 15% in Q2 2026, selling an estimated $339K and leaving 285,186 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2116.

UBS AM first reported a position in ENVX in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.93M in Q2 2025. 298 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • UBS AM held 285,186 shares of Enovix worth $1.73M as of Q2 2026.
  • UBS AM sold 51,194 Enovix shares in Q2 2026, an estimated $339K.
  • Enovix made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2116 holding.
  • UBS AM first reported a position in Enovix in Q4 2021 and has held it in 19 quarters since.
  • UBS AM's Enovix position peaked at $5.93M in Q2 2025.
  • 298 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.